Another peptide related to inflammatory changes in AD, soluble Trem2 (sTrem2) has also been found increased in CSF samples of MCI and early-AD patients, whereas its levels decrease at more advanced stages of the disease [44]. The gene discussed is TREM2; the disease is Alzheimer disease.